Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Selective suppression of Th1 cytokine production with TAK-603

Oct. 21, 1997

U.S. testing of Toyama antiarthritic to begin soon

Oct. 20, 1997

BASF prepares anti-hTNF-alpha antibodies

Oct. 20, 1997

Prodrugs of selective COX-2 inhibitors

Oct. 20, 1997

P&G develops dihydrobenzofuran compounds for inflammation

Oct. 17, 1997

COX-2 inhibitors from Chugai

Oct. 17, 1997

New antiarthritic agents described by Procter & Gamble

Oct. 15, 1997

Verigen licenses Italian rights to anti-TNF-alpha product

Oct. 14, 1997

Eltenac efficacy demonstrated in osteoarthritis

Oct. 13, 1997

FDA grant awarded for research on Dupuytren's disease therapy

Oct. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...